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The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-
independent pathways that cooperate to transform NIH3T3 cells
Pierre Roux, Cécile Gauthier-Rouvière, Sandrine Doucet-Brutin and 
Philippe Fort
Background: Ras-mediated transformation of mammalian cells has been
shown to activate multiple signalling pathways, including those involving
mitogen-activated protein kinases and the small GTPase Rho. Members of the
Rho family affect cell morphology by controlling the formation of actin-
dependent structures: specifically, filopodia are induced by Cdc42Hs,
lamellipodia and ruffles by Rac, and stress fibers by RhoA. In addition, Rho
GTPases are involved in progression through the G1 phase of the cell cycle,
and Rac1 and RhoA have recently been directly implicated in the morphogenic
and mitogenic responses to transformation by oncogenic Ras. In order to
examine the cross-talk between Ras and Rho proteins, we investigated the
effects on focus-forming activity and cell growth of the Rho-family members
Cdc42Hs, Rac1 and RhoG by expressing constitutively active or dominant-
negative forms in NIH3T3 cells.
Results: Expression of Rac1 or RhoG modulated the saturation density to
which the cells grew, probably by affecting the level of contact inhibition.
Although all three GTPases were required for cell transformation mediated by
Ras but not by constitutively active Raf, the selective activation of each GTPase
was not sufficient to induce the formation of foci. The coordinated activation of
Cdc42Hs, RhoG and Rac1, however, elicited a high focus-forming activity,
independent of the mitogen-activated ERK and JNK protein kinase pathways. 
Conclusions: Ras-mediated transformation induces extensive changes in cell
morphology which require the activity of members of the Rho family of
GTPases. Our data show that the pattern of coordinated Rho family activation
that elicits a focus-forming activity in NIH3T3 cells is distinct from the regulatory
cascade that has been proposed for the control of actin-dependent structures
in Swiss 3T3 cells.
Background
In mammalian cells, the expression of oncogenic Ras pro-
teins has been shown to activate mitogenesis, as well as to
cause extensive changes in cell morphology. Activation of
mitogenesis relies on the pathways involving Raf, Mek
and the extracellular signal regulated kinases (ERKs, also
called mitogen-activated protein or MAP kinases), the
individual components of which have also been described
as capable of transforming cells [1]. Analysis of Ras
mutants impaired in binding to Raf has revealed that Ras-
induced transformation requires the activation of the Raf
pathway, and also of two Raf-independent pathways, at
least one of which is Rho-dependent [2,3].
Members of the Rho family of small GTPases have been
implicated in the signal transduction pathways involved in
the control of cell morphology and motile activity. The
Rho family includes Rho (A, B, C), RhoE, RhoL, Rac (1
and 2), RhoG, Cdc42Hs and TC10 [4–9]. In fibroblastic
cells, Cdc42Hs regulates the formation of filopodia, Rac
the formation of membrane ruffles and lamellipodia, and
Rho the formation of focal adhesion plaques and actin
stress fibres [10–15]. More recently, Rho family members
have also been shown to be essential for cell growth:
RhoA, Rac1 and Cdc42Hs promote cell cycle progression
through the G1 phase, up to the point of S phase entry
[16]. Furthermore, three other Rho family members have
been shown to be encoded by genes activated upon extra-
cellular signal stimulation: Rac2, a hemopoietic lineage-
specific GTPase closely related to Rac1 [17]; RhoB, which
is closely related to RhoA and encoded by an immediate-
early growth response gene [18]; and RhoG, which is
related to Rac1 and Cdc42Hs, and whose mRNA accumu-
lates during the late G1 phase in growth-stimulated
fibroblasts [9]. In addition, Cdc42Hs and Rac1 activate the
Jun N-terminal kinase/stress-activated protein kinase
(JNK/SAPK) [19,20], leading to subsequent gene activa-
tion driven by the serum response factor (SRF) [21]. 
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Further evidence for a role of Rho family members in Ras-
mediated transformation was provided by the observation
that dominant-negative mutants of Rac1, RhoA and RhoB
inhibit Ras-induced transformation [22–25]. Activated ver-
sions of these proteins have a low transforming potential,
eliciting foci that are morphologically distinct from those
induced by Ras and are formed of aggregates of non-
refractile, piled-up cells. Foci of similar morphology are
also produced — at a higher frequency — by the onco-
genic versions of guanine exchange factors (GEFs), such
as Vav or Dbl, that act on Rho family members [26]. In the
present study, we investigated the effects of RhoG
protein, containing either an activating or an inhibitory
mutation, on cell proliferation and on Ras-mediated and
Raf-mediated transformation, as well as the relationships
of RhoG with Rac1 and Cdc42Hs.
Results
Activation of RhoG and Rac1 but not Cdc42Hs increases
cell saturation density
It was recently reported that cells expressing constitu-
tively active Rac1, which contains a valine substitution at
position 12 (Rac1-V12), grew at a higher saturation
density than normal cells as a result of a partial loss of
contact inhibition [25]. In order to compare the effects of
RhoG, Rac and Cdc42Hs, we produced retroviruses
directing the expression of activated (V12) and inhibitory
(N17) RhoG proteins tagged with the hemagglutinin
epitope (HA), and Rac1 and Cdc42Hs proteins tagged
with the Myc epitope, and used them to infect NIH3T3
cells. The specificity of the N17 dominant-negative forms
of Rac1 and Cdc42Hs was previously demonstrated by
their effects on the Rac-dependent membrane ruffling
induced by epidermal growth factor (EGF), the Cdc42Hs-
dependent induction of filopodia by bradykinin, and the
RhoA-dependent stress fiber formation induced by
lysophosphatidic acid (LPA). Using a similar approach, we
showed that expression of RhoG-N17 did not impair the
formation of ruffles, filopodia or stress fibers (data not
shown). An extensive study of the actin structure and
morphology of fibroblasts expressing activated and domi-
nant-negative RhoG will be described elsewhere (C.G-R.,
unpublished observations). 
Expression of the retrovirally expressed proteins was mon-
itored by western blotting (Figure 1a). Expression of
RhoG-V12 led to an overall increased proliferation of the
infected cells (Figure 1b). Time-course analysis indicated
that the infected cells displayed a slightly longer doubling
time but grew at a higher saturation density (60%
increase) than NIH3T3 control cells infected with wild-
type pLXSN particles (Table 1). Conversely, cells
expressing RhoG-N17 had an increased doubling time
during the first day, then grew at the same rate as control
cells, and stopped growing at a 45% lower saturation
density (Figure 1b). The use of 20-fold and 200-fold
higher viral particle concentrations for the infection
elicited a 4-fold and 11-fold increase in RhoG-N17 expres-
sion (Figure 1a), which led to a further 10% and 50%
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Figure 1
Changes in cell saturation density upon expression of RhoG, Rac1 or
Cdc42Hs. (a) NIH3T3 cells (105) were infected with 105 colony forming
units (cfu) pLXSN wild-type particles (C1, C2 and C3) or particles
expressing HA-tagged RhoG-V12 or RhoG-N17, or Myc-tagged
Cdc42Hs-V12, Cdc42Hs-N17, Rac1-V12 or Rac1-N17. Total proteins
from infected cells (40 µg) were analysed by gel electrophoresis
followed by western blotting with 12CA5 anti-HA and 9E10 anti-Myc
monoclonal antibodies. The increase in RhoG-N17 protein expression in
cells infected with 2 × 106 cfu (20x RhoG-N17) and 2 × 107 cfu (200x
RhoG-N17) is shown. Signals, quantified with the Intelligent Quantifier
software (Millipore), are indicated below the lanes, and size markers are
indicated on the left. (b,c) Infected cells were seeded in 6-well dishes at
5 × 103 cells per well. Cell number was determined after trypsinization.
(b) Growth kinetics of RhoG-expressing NIH3T3 cells. Results are the
mean of four independent experiments; SEMs (all lower than 5%) are not
shown. (c) Cells expressing RhoG, Rac1 or Cdc42Hs were grown to
saturation, corresponding to day 5 in (b). The means and SEMs
calculated for six independent experiments are shown.
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reduction of the saturation density, respectively (Figure
1b). Identical results were observed using NIH3T3 cells
stably transfected with plasmid DNA directing the expres-
sion of the same mutant RhoG proteins, indicating that the
observed effects were independent of the expression pro-
cedure. Expression of Rac1-V12 led to a 90% increase in
the cell density at the plateau, whereas expression of
Rac1-N17 led to a 40–45% drop in cell density (Figure 1c),
in agreement with previously published data [25]. In con-
trast, Cdc42Hs-V12 expression led to a very limited effect
(less than 10%), whereas a 40–45% drop in cell density was
observed upon Cdc42Hs-N17 expression, which is within
the range of the effects observed using RhoG and Rac1. 
Focus formation induced by Ras-V12 requires and is
potentiated by RhoG, Rac1 and Cdc42Hs activity
We next examined the role of RhoG, Rac1 and Cdc42Hs
in focus formation by NIH3T3 cells, using transfection
and retroviral infection procedures. Rac activity has previ-
ously been shown to be insufficient to promote focus for-
mation but necessary for Ras-induced transformation
[23,25]. We therefore investigated whether RhoG and
Cdc42Hs had similar properties. Transfected Ras-V12
alone produced approximately 5 × 103 transformed foci per
µg of transfected DNA (corresponding to 100% in Figure
2), which is within the range of previously published data
[23,25,27]. RhoG-V12, Rac1-V12 and Cdc42Hs-V12 had
very little intrinsic focus-forming activity, if any (less than
four transformed foci per µg transfected DNA). Cotrans-
fection of 2 ng of vector encoding Ras-V12 with vectors
encoding the activated versions of RhoG, Rac1 or
Cdc42Hs (50 ng or 500 ng) led to a two-fold, four-fold and
three-fold increase in the number of foci, respectively,
indicating a cooperative effect of each Rho GTPase with
Ras-V12. The cooperation was particularly efficient with
Rac1-V12, which required a DNA input 10-fold lower than
RhoG-V12 and Cdc42Hs-V12. On the other hand, co-
expression of the N17 dominant-negative mutant forms
led to a 50% (RhoG), 60% (Cdc42Hs) or 80% (Rac1)
decrease in the number of foci, indicating that the activity
of each GTPase is required for focus formation mediated
by Ras-V12. The values obtained for both Rac1 mutants
are within the range of published results [23,25]. 
Cdc42Hs, RhoG and Rac1 cooperate in focus formation
The preceding results suggested that RhoG, Rac1 and
Cdc42Hs might mediate several Ras-V12-dependent
pathways that lead to focus formation. This notion is
supported by the oncogenic potential of many GEFs that
activate several members of the Rho family [15,28–32]. In
order to determine whether RhoG, Rac1 and Cdc42Hs
might activate distinct cooperative pathways, we first
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Figure 2
Effects of activated and dominant-negative forms of RhoG, Rac1 and
Cdc42Hs on Ras-V12 focus-forming activity. NIH 3T3 cells (105) were
either transfected with 500 ng vector expressing RhoG-V12,
Cdc42Hs-V12 or Rac1-V12, or cotransfected with 1µg DNA containing
2 ng pECEG12V-ras (encoding Ras-V12) and 50 ng or 500 ng of
construct expressing RhoG-V12, Cdc42Hs-V12 or Rac1-V12, or 1µg
plasmid DNA expressing the dominant-negative forms. Empty pCDNA3
was used as a negative control. After the cells reached confluence, each
culture was split into four dishes and the concentration of fetal calf
serum was reduced from 10% to 4%. The number of foci was scored
14 days later, and is expressed as a proportion of the foci induced by
Ras-V12 (100%). The mean of two independent assays done in
triplicate is shown; error bars indicate the SEM.
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Table 1
Saturation densities of NIH3T3 cells expressing active or
dominant-negative GTPases.
Saturation density (cell number on day 5)
Cells Mean (× 10–3) SEM (× 10–3)
Control 779.5 7.5
RhoG-V12 1121.9 6.0
Rac1-V12 1319.6 17.6
Cdc42Hs-V12 806.2 3.9
RhoG-N17 (1×) 301.4 1.3
RhoG-N17 (20×) 273.2 1.8
RhoG-N17 (200×) 230.0 1.6
Rac1-N17 (1×) 393.1 1.4
Cdc42Hs-N17 (1×) 406.1 3.8
Infected cells were seeded in 6-well dishes at 5 × 103 cells per well
and grown for 5 days to saturation. The means and SEMs were
calculated from six independent experiments.
performed focus formation assays on NIH3T3 cells con-
comitantly expressing the three activated RhoG, Rac1 and
Cdc42Hs mutants (Figure 3). For these assays, 50 ng
expression plasmid was used, a DNA input at which very
low or no focus-forming activity was observed for each con-
struct (see Figure 2). Coexpression of all three Rho
GTPases led to an average of ~103 foci per µg of input
DNA — that is, about 20% of Ras-V12 activity and more
than two orders of magnitude higher than the focus-forming
activity elicited by each GTPase alone. This prompted us
to examine the effects of pairwise combinations. 
Using the same amounts of each DNA (50 ng), coexpres-
sion of RhoG-V12 and Rac1-V12, RhoG-V12 and
Cdc42Hs-V12, and Rac1-V12 and Cdc42Hs-V12 led to an
average of 35, 80 and 480 foci per µg input DNA, respec-
tively. Cdc42Hs-V12 with Rac1-V12 therefore represents
the most efficient combination (giving up to 10% of Ras-
V12 focus-forming activity), suggesting that the two
GTPases control cooperative pathways, in agreement with
their differential effects on contact inhibition. Conversely,
the combination of RhoG-V12 and Rac1-V12, both of
which decrease contact inhibition, had the lowest focus-
forming activity, suggesting that these GTPases control
some pathways in common. To address this latter issue,
we coexpressed each pair of activated GTPases with the
dominant-negative version of the third one (grey boxes,
Figure 3). Expression of Rac-N17 led to a significant inhi-
bition (up to 80%) of the focus-forming activity of
Cdc42Hs-V12 plus RhoG-V12, whereas RhoG-N17 only
partially reduced the number of foci elicited by Rac-V12
plus Cdc42Hs-V12. Although these data might fit several
regulatory schemes, they rather suggest that the endoge-
nous Rac1 protein might control an essential step down-
stream of RhoG-V12 and Cdc42Hs-V12. In contrast,
expression of Cdc42Hs-N17 did not reduce the focus-
forming activity of Rac1-V12 plus RhoG-V12, indicating
that the action of these two GTPases is independent of
endogenous Cdc42Hs. 
Focus formation mediated by Cdc42Hs, RhoG and Rac1
uses pathways distinct from the Raf/Mek/ERK pathway
Activation of the ERK pathway by the translocation and
phosphorylation of cellular Raf-1 has long been known to
be necessary for cell transformation mediated by Ras-V12
[33,34]. We thus investigated the relationships between
the ERK pathway and the pathways controlled by
Cdc42Hs, RhoG and Rac1. We first examined the effect
of the activated and inhibitory forms of RhoG, Rac1 and
Cdc42Hs on focus formation in NIH3T3 cells expressing
v-Raf, the viral oncogenic form of cellular Raf-1. The
average number of foci produced by v-Raf alone was about
102 per µg transfected DNA (indicated as 100% in Figure
4a), which corresponds to 2–5% of the number obtained
with Ras-V12 (see Figure 3). Coexpression of v-Raf and
the inhibitory forms of RhoG, Rac1 and Cdc42Hs did not
reduce the number of foci. Conversely, coexpression of
v-Raf with Rac1-V12 and RhoG-V12 elicited a three-fold
to eight-fold increase in the foci number. The increase
observed for Rac1 is within the range of previously pub-
lished data [25]. RhoG requires a higher DNA input for
cooperating with Ras-V12 and v-Raf, a feature that might
reflect a difference in protein level or activity. Interest-
ingly, coexpression of Cdc42Hs-N17 or Cdc42Hs-V12 had
no effect on Raf transformation, a finding which further
strengthens the notion that Cdc42Hs controls pathways
distinct from RhoG and Rac1. 
Although the endogenous activity of RhoG, Rac1 and
Cdc42Hs GTPases is not crucial for transformation medi-
ated by v-Raf, each of them is necessary for transformation
mediated by Ras-V12, suggesting that signal transduction
from Ras to Raf might be affected by Rho-dependent
pathways. To address this issue, we examined the effects
of RhoG, Rac1 and Cdc42Hs on the activity of the MAP
kinase ERK2, activation of which is triggered by Raf.
Coexpression of HA-tagged forms of ERK2 and the
mutated forms of either RhoG, Rac1 or Cdc42Hs was
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Figure 3
Cdc42Hs, RhoG and Rac1 cooperate in focus formation. NIH3T3
cells (105) were transfected with 1 µg DNA containing either empty
pECE vector as a negative control, 25 ng pECEG12V-Ras (encoding
Ras-V12) as a positive control, or various combinations of constructs
expressing the V12-activated Rho GTPases (50 ng) and the N17-
dominant-negative versions (1 µg), as indicated. Focus formation
assays were performed as described in Figure 2 and the number of
foci per µg is expressed as a proportion of those induced by 25 ng of
pECEG12V-Ras. Error bars indicate the SEM of two independent
experiments done in triplicate.
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achieved by transient cotransfection of NIH3T3 cells, and
kinase activity was assayed after immunoprecipitation
using an anti-HA antibody. As observed in Figure 4b,
expression of the N17-mutated GTPases did not reduced
Ras-V12-mediated ERK2 activation, demonstrating that
the inhibitory effect of the N17 GTPases is not correlated
with an impairment of Raf activation. Instead, we
observed a two-fold to three-fold induction of the activity
of the exogenous ERK2 upon expression of Rac1-N17 and
RhoG-N17, suggesting that inhibition of either of the
GTPases might increase the Ras/Raf signalling or
decrease its downregulation. 
We next investigated the effect of the activated GTPases
on ERK2 activation (Figure 4c). Expression of any of the
three GTPases had no significant effect on ERK2 activa-
tion in resting cells. Thus, the cooperative effect of
RhoG-V12 and Rac1-V12 with v-Raf is not mediated by an
increase in ERK2 activity. Besides, coexpression of any
combination of the V12-GTPases failed to activate ERK2,
indicating that the high focus-forming activity elicited by
the coordinate activation of Cdc42Hs, RhoG and Rac1 is
independent of ERK2 activation. Similarly, no change in
ERK2 activity was detected in foci generated from the
combination of RhoG-V12, Rac1-V12 and Cdc42Hs-V12
(data not shown). 
Constitutively active RhoG, Rac1 and Cdc42Hs do not
cooperate to activate the JNK pathway
Activation of Rac1 and Cdc42Hs has been previously rep-
orted to activate the JNK pathway but to have no effect on
the ERK2 pathway [19,20,35]. In order to determine
whether the focus formation controlled by the interaction
of Cdc42Hs and RhoG or Rac1 could be associated with a
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Cdc42Hs, RhoG and Rac1 cooperate independently of the Raf/Mek/
ERK2 pathway. (a) NIH3T3 cells (105) were transfected with 100 ng
pECEG-v-raf (encoding v-Raf), either alone or in combination with
vectors expressing the V12-activated Rho GTPases (50 ng or 500 ng)
or the N17-dominant-negative versions (1µg). As a control, cells
transfected with empty pECE vector were used. Focus formation was
assayed as in Figure 2; error bars indicate the SEMs of two independent
experiments done in triplicate. (b,c) NIH3T3 cells were either transfected
only with a vector directing the expression of HA–ERK2 (control) or
cotransfected with the HA–ERK2 vector, pECEG12V-ras (encoding
Ras-V12) and either empty vector (pCDNA3) or constructs expressing
RhoG-N17, Rac1-N17 or Cdc42Hs-N17. (b) The ERK2 activities in the
cell lysates were measured by immunocomplex kinase assays using
myelin basic protein (MBP) as a substrate, and the extent of the
stimulation was quantified with a phosphorimager and is expressed
relative to the control cells. (c) HA–ERK2 expression in transfected cells
was controlled by western blot analysis using an anti-HA antibody. (d,e)
NIH3T3 cells were cotransfected with 1mg total plasmid DNA, a
combination of pECEHAp44MAPK and either the empty vector (control)
or constructs expressing the indicated GTPases. (d) ERK2 activity and
(e) ERK2 expression were measured as in (b,c). The data shown in (b–e)
are representative of two independent experiments.
quantitative change in JNK activity, we performed the
experiments presented in Figure 5. We first checked
whether Ras-V12-mediated JNK activation was depen-
dent on RhoG, Rac1 and Cdc42Hs activity. NIH3T3 cells
were transiently cotransfected to express HA-tagged ver-
sions of JNK and each of the inhibitory versions of RhoG,
Rac1 or Cdc42Hs. As shown in Figure 5a, expression of
either one of the mutated GTPases prevented the Ras-
mediated JNK activation, as has been described previ-
ously for Rac1 and Cdc42Hs [19,20]. We next analysed
the effect of expressing the activated GTPases, either
alone or in combination (Figure 5b). Cdc42Hs-V12 and
Rac1-V12 led to a 17-fold and a 6-fold increase in JNK
activity, respectively, in agreement with previous reports
[19,20]. Expression of RhoG-V12 led to an 8-fold
increase, which is within the range of that elicited by
Rac1-V12. When different combinations were used,
however, the effects on JNK activity were not additive:
the resulting JNK activity was identical to that induced
by the most potent GTPase used in the combination.
This indicates that no major change in JNK activation is
associated with the focus-forming activity elicited by the
association of Cdc42Hs, Rac1 and RhoG. Similar levels of
JNK activity were observed in cells derived from foci gen-
erated from the coexpression of the three V12-GTPases
(data not shown). 
Discussion
Several reports have implicated Rho family members in
the processes of cell proliferation and transformation.
First, Rac1, Cdc42Hs and RhoA are required for cell cycle
progression from G0 through to the G1 phase [16] and
modulate transcriptional activity mediated by SRF [21].
In addition, Rac1 and Cdc42Hs activate the JNK
pathway, inducing changes in the pattern of gene tran-
scription [19,20,35]. Second, the members of the Dbl
family of oncogenes all contain a common domain that
stimulates GDP–GTP exchange for Rho GTPases and is
necessary for the oncogenic properties of the Dbl family
[15,29]. And third, Ras-induced, but not Raf-induced,
transformation is blocked by the expression of dominant-
negative mutants of Rac1, RhoA and RhoB, whereas
expression of constitutively active Rac1 or RhoA acts syn-
ergistically with activated Raf to transform cells [22–25].
In this study, we investigated the contributions of
Cdc42Hs and RhoG to the control of cell proliferation and
transformation, as well as their regulatory cross-talks with
Rac1, Ras and Raf. 
Our data showed that activation of RhoG led to a modula-
tion of cell saturation density, as has previously been
shown for Rac1 [25]. This might account for the low co-
operativity in focus formation displayed by these two
GTPases when expressed together, and might suggest
that they are involved in a common pathway controlling
cell contact inhibition. RhoG might act usptream of Rac1,
as expression of RhoG-N17 has little effect on the focus-
forming activity of Rac1/Cdc42Hs, whereas Rac1-N17
inhibits the focus-forming activity of RhoG/Cdc42Hs.
This suggestion agrees well with our unpublished results
showing that RhoG requires endogenous Rac1 activity to
elicit ruffling in Swiss 3T3 cells (C.G-R., unpublished
634 Current Biology, Vol 7 No 9
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Cdc42Hs, RhoG and Rac1 cooperate independently of the JNK/SAPK
pathway. (a,b) NIH3T3 cells were cotransfected with 1 µg total
plasmid DNA containing pSRα.3HA.JNK1 (encoding HA–JNK),
pECEG12V-ras (encoding Ras-V12) and either empty pCDNA3 or
constructs expressing the indicated N17-mutated GTPases. As a
control, cells were transfected with DNA containing pSRα.3HA.JNK1
only. (a) JNK activities in the cell lysates were measured by
immunocomplex kinase assays using, as a substrate, a fusion protein
of glutathione-S-transferase and cellular Jun (GST–c-Jun). The extent
of the stimulation was quantified using phosphorimager screens and
expressed as a multiple of the signal from control cells. (b) HA–JNK
expression in transfected cells was analysed by western blot using an
anti-HA antibody. (c,d) NIH3T3 cells were cotransfected with
pSRα.3HA.JNK1 and either empty pCDNA3 (control), pECEG12V-ras,
or different combinations of constructs expressing the V12-mutated
GTPases, as indicated. (c) JNK activity and (d) the level of JNK
expression were analysed as for (a,b). Data shown in (a–d) are
representative of two experiments.
observations). The case for Rac1 being downstream of
RhoG is further strengthened by the observation that
dominant-negative Rac1 is the most potent inhibitor of
Ras-V12-mediated transformation. The failure of RhoG
and Rac1 to elicit focus formation is consistent with the
results of Tiam1 characterizations. Tiam1 is an exchange
factor for Rac1, and oncogenic versions of Tiam1 elicit
tumours with a high invasive and metastatic potential
[15]. Tiam1 was shown to induce relatively dense areas of
epithelium-like cells that grew as monolayers [30], indicat-
ing that although Rac1 activation leads to a reduction in
contact inhibition, additional signals are required for the
formation of multilayers by NIH3T3 cells. Such signals
might be mediated through Cdc42Hs, which delineates a
distinct pathway, as it has no effect on saturation density
and promotes focus-forming activity when coexpressed
with Rac1, reaching 10% of the activity of Ras-V12. A
third pathway might be controlled by RhoA, which was
previously reported to be involved in Ras-mediated trans-
formation: although it has a very low transforming poten-
tial on its own, RhoA strongly cooperates with weakly
transforming Raf mutants, and expression of dominant-
negative RhoA-N19 reverts Ras-mediated transformation
[23,25]. Cooperativity between Rho GTPases in focus for-
mation is in keeping with the densely packed morphology
of foci induced by exchange factors such as Dbl, Vav, Ect2
or Ost, which might act simultaneously on distinct
GTPases [26,28,32,36]. 
Interestingly, the focus-forming activity elicited by the
association of RhoG, Rac1 and Cdc42Hs uses pathways
independent of the ERK2 and JNK MAP kinases. JNK
activity is enhanced in cells expressing Cdc42Hs-V12 or
Rac1-V12, as previously reported [16,19,20], and we have
shown that this is also the case for RhoG-V12. However,
no increase in JNK activity was detected in cells express-
ing any focus-forming combination of GTPases when com-
pared to cells expressing only Cdc42Hs, the most potent
JNK activator. This is in agreement with the finding that
JNK activation is not required for Rac-induced prolifera-
tion, for G1 cell cycle progression induced by Rac or
Cdc42, or for actin polymerization [37,38]. Ras-dependent
transformation was shown to be impaired upon inhibition
of the activity of ERK1 or ERK2 [23] or Mek [1,39]. Nev-
ertheless, a doubly mutated Ras (Glu12→Val,
Thr35→Ser) was reported to be defective for its transform-
ing properties, although it could nevertheless activate the
ERK cascade and stimulate SRE-dependent gene tran-
scription [2]. Our own data show that inhibition of
Cdc42Hs, Rac1 or RhoG decreases Ras-mediated transfor-
mation without any inhibition of ERK2 activation. Con-
versely, the coordinated activation of Rac1, RhoG and
Cdc42Hs gives a high focus-forming activity without any
change in ERK2 activation. The resulting foci have a mor-
phology distinct from Ras-V12-transformed cells, however,
suggesting that activation of the Raf/Mek/ERK2 pathway
is required, in addition to Rho pathways, to produce a fully
transformed phenotype.
Conclusions
Our present analysis shows that coordinated activation of
the Cdc42Hs, Rac1 and RhoG GTPases elicited a high
focus-forming activity in NIH3T3 cells, whereas expres-
sion of each of them alone failed to induce foci. This
effect of coordinated activation cannot be explained by
the regulatory linear cascade proposed for actin-depen-
dent cytoskeletal reorganisation in Swiss 3T3 cells, in
which Cdc42Hs activation was shown to activate Rac1
which in turn activates RhoA [10–13,16]. We propose that
additional pathways, independent of the ERK2 and JNK
kinases, are involved in the process of focus formation.
One pathway modulates cell contact inhibition and is gov-
erned by Rac1 and, to a lesser extent, RhoG. A second
pathway, acting independently, is controlled by Cdc42Hs.
Detailed analysis of the morphological changes induced in
the ‘Rho-like’ foci, as well as knowledge of the cross-talks
between RhoA and the RhoG/Rac1/Cdc42Hs GTPases,
are now required, in order to determine which additional
pathways are involved and what impact they have on the
process of focus formation.
Materials and methods
DNA constructs and site directed mutagenesis
The wild-type RhoG open reading frame (ORF) was amplified using the
polymerase chain reaction (PCR) and the amplimers 5′-dCG-
GAATTCATGCAGAGCATCAAGTG-3′ and 5′-dGCTCTAGAGGTCA-
CAAGAGGATGCA-3′; PCR products were cloned into the EcoR1
and Xba1 sites of pT7T318U (Pharmacia). Mutated ORFs (Gly12→Val
and Thr17→Asn) were generated by site-directed mutagenesis of
uridylated phagemid single-stranded DNA, as described by Wang et al.
[40] using the oligonucleotides 5′-dCTTGCCCACAGCGACGTCAC-
CCACCACp-3′ (Gly12→Val), 5′-dGCAGGCAATTCTTGCCCACAG-
CGCCGTCACCp-3′ (Thr17→Asn) and 5’-dCGAACACGGCCGGG-
ATGTACTCp-3′ (Thr35→Ala). The presence of mutations was
checked by DNA sequencing. The mutated ORFs were subcloned into
the EcoRI and XbaI sites of pCDFT [41], a derivative of pCDNA3 allow-
ing expression of HA-tagged proteins, to give pCDNA-rhoG-V12, and
pCDNA-rhoG-N17.
To express HA-tagged RhoG proteins by retroviral infection, the
oligonucleotide 5′-dAATTGCCACCATGTATGATGTTCCTGATTATG-
CTAGCCTCGAATTCAAC-3′ encoding the HA epitope was inserted
into pLXSN, a MoMuLV-derived vector expressing resistance to the
drug G418, giving pLXSN-HA. RhoG mutated ORFs were then sub-
cloned into the EcoRI and SalI sites of pLXSN-HA, to give pLXSN-
RhoG-V12 and pLXSN-RhoG-N17. The ORFs encoding Myc-epitope
tagged mutated versions of Rac1 and Cdc42Hs were excised from
pMT90-derived constructs (kindly provided by Philippe Chavrier, CIML,
Marseille) and subcloned into a pLXSN-derived vector, containing a
NotI site instead of its HpaI site, to give pLXSN-Cdc42HS-V12,
pLXSN-Cdc42HS-N17, pLXSN-Rac1-V12 and pLXSN-Rac1-N17. 
Cell culture and retroviral particle production
NIH3T3 and virus producer GP+E-86 were cultured in 4.5 g/l Dulbec-
co’s Modified Eagle’s Medium (DMEM) containing 10% fetal calf serum
(FCS; Bio Media) at 37°C in a humidified atmosphere (95% air; 5%
CO2). Transfections into GP+E-86 cells were performed using the Lipo-
fectamin method, as recommended by the supplier (Gibco-BRL).
Neomycin-resistant clones were selected with 600µg/ml G418 and then
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pooled. Ecotropic retroviral particles were prepared by harvesting 10 ml
normal medium, applied 18 h previously, from a confluent monolayer of a
100 mm dish of GP+E-86 virus-producing cells and then filtering the
medium through a 0.45 µm filter (Millipore). To estimate retroviral titers,
NIH3T3 cells were infected by incubating a 100 mm plate containing
5 × 105 cells with 2 ml viral supernatant, or a dilution thereof, in the pres-
ence of 5 µg/ml Polybrene (Aldrich) for 5 h. Medium (8 ml) was added
and the cells were then grown to confluence for 2 days before being split
into selective medium (600 mg/ml G418). After 10 days of selection, the
resistant colonies were counted and retroviral titers were expressed as
the number of colony forming units (cfu) per ml retroviral medium.
Focus formation assay
Briefly, 105 NIH3T3 cells were cotransfected with 1mg total DNA con-
taining different combinations of vectors expressing Ras-V12, v-Raf or
the mutated versions of RhoG, Rac and Cdc42Hs, using lipofection (8µl
Lipofectamin in 800 ml OptiMEM (Gibco-BRL) for 5 h) on 6 cm dishes.
Alternatively, cells were first transfected then, 24 h later, infected
overnight with retroviral particles (2× 105 cfu) expressing the different
mutant forms of RhoG, Rac1 and Cdc42Hs in the presence of 5mg/ml
Polybrene. After cells reached confluency, each 6 cm dish was split into
four 6 cm diameter dishes and the FCS concentration was reduced from
10% to 4%. Medium was changed every 2.5 days. Cells were fixed
12–14 days later and stained with a solution containing 30% methanol
and 0.4% crystal violet. Foci larger than 1 mm in diameter were scored.
MAP kinase assays
NIH3T3 cells (5 × 105) were seeded into each well of six-well plates.
Cells were transfected 18 h later with 0.5µg of each plasmid DNA,
expressing either HA–JNK1 (pSRα.3HA.JNK1) or HA–ERK2
(pECEHAp44MAPK) and the small GTPases to be tested, using 4µl
Lipofectamin for 5 h in OptiMEM. Cells were then left for 24 h in DMEM
without serum and harvested in Triton Lysis Buffer (TLB) containing
20 mM Tris-HCl (pH 7.5), 137 mM NaCl, 2 mM EDTA, 1% Triton X-100,
1 mM β-glycerophosphate, 1 mM sodium orthovanadate, 10% glycerol,
1 mM PMSF and 10 µg/ml leupeptin. Soluble extracts were prepared by
centrifugation at 15,000 rpm for 30 min at 4°C. Extracts were separated
into 2 fractions: the first one to test the expression of the tagged MAP
kinase and of the transfected small GTPases, and the second to assay
for ERK2 or JNK activities as follows: extracts were incubated with 5µl
anti-HA monoclonal antibody 12CA5 pre-bound to 20ml protein-G-
Sepharose (Pharmacia). After a 2 h incubation at 4°C, the immunoprecip-
itates were washed three times with TLB and twice with kinase buffer
containing 25 mM Hepes (pH 7.5), 25 mM MgCl2, 25 mM β-glyc-
erophosphate, 2 mM DTT and 0.1 mM sodium orthovanadate. Immuno-
complex kinase assays were performed at 30°C for 30 min using 4µg
substrate (myelin basic protein (Sigma) for ERK2 activities, and GST–c-
Jun(1–79) for JNK activities), 50µM ATP and 10 µCi γ-[32P]ATP in 20 µl
kinase buffer. The reactions were stopped with Laemmli sample buffer
and the products were resolved by gel electrophoresis (10% polyacry-
lamide gels for JNK assays and 15% polyacrylamide gels for ERK2
assays). Dried gels were exposed on imaging plates for 1 h, and signals
were quantified with a phosphorimager (Molecular Dynamics).
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